«ScienceRise: Pharmaceutical Science» – scientific peer-reviewed journal, published 6 times a year, included in category «A» «List of scientific professional editions of Ukraine» (Сertificated by order of Ministry of Education and Science of Ukraine No. 420 from 19.04.2021).

Registration of an entity in the media sector: Decision of the National Council of Ukraine on Television and Radio Broadcasting No. 695 dated August 10, 2023, protocol No. 17 (media identifier R30-01130).

The main mission of the journal – dissemination of the results of scientific research aimed at ensuring the quality of pharmaceutical assistance to the population through targeted search and modern pharmaceutical development of innovative medicines, the creation of modern quality management systems at pharmaceutical enterprises in the industry.

In the journal «ScienceRise: Pharmaceutical Science» publishes research designed and implemented taking into account the Quality by design concept with widespread use of computational methods.

The journal is intended for scientists, pharmacists, doctors, educators, and healthcare professionals.

Innovations in pharmaceutical science - for practical use.

ISSN 2519-4844, E-ISSN 2519-4852, ISSN-L 2519-4844

Drawing up the items of the publication ethics policy of the journal «ScienceRise: Pharmaceutical Science» Editors followed the recommendations of Committee on Publication Ethics (COPE).

Announcements

Letter from the TECHNOLOGY CENTER regarding the mass use of artificial intelligence in articles

2025-11-18

Dear colleagues!

This letter concerns the problem of mass use of artificial intelligence (AI) by authors. You can also watch a video of the letter https://www.youtube.com/watch?v=QiKR9-aZlxA

Recently, the world's leading indexing resources have begun mass checks of journals for the use of AI in published articles. Due to the discovery of mass use of AI to create scientific publications by authors, journals in which inappropriate use of AI in articles is detected are removed from the resources, including complete deindexation of published articles.

As a result: the author loses all his/her articles in such publications, index, and declared publications in reports, dissertations, grants, confirmation of compliance with the License Terms are canceled.

Currently, hundreds of published articles around the world have already been withdrawn by publishers, and this is just the beginning.

Leading publishers in the world withdraw publications if the use of AI by authors exceeds acceptable norms. The justification for such actions is obvious – improper use of AI actually nullifies the quality of scientific publications and is a fact of falsification and manipulation of data by the authors.

What can be the consequences for the author for improper use of AI: withdrawal of published articles (while the articles remain accessible with an appropriate note of withdrawal) and penalties in accordance with the terms of the agreements concluded with the publishers.

Therefore, please carefully read the Editorial Policy regarding the proper use of AI and strictly adhere to it when preparing the manuscript of the article and before submission.

Our goal is to present to the world you as a scientist and your personal best scientific developments, not artificially generated content.

With respect and care for you,
TECHNOLOGY CENTER PC®

Be sure to check out our previous video on the use of artificial intelligence:

WHY AUTHORS SHOULD NOT RELY ON ARTIFICIAL INTELLIGENCE WHEN PREPARING A REFERENCE LIST
USED AI BUT DIDN'T DECLARE IT? WHAT ARE THE RISKS FOR AUTHORS?

Read more about Letter from the TECHNOLOGY CENTER regarding the mass use of artificial intelligence in articles

Current Issue

No. 5 (57) (2025)
View No. 5 (57) (2025)
Published: 2025-10-31

Full Issue

Pharmaceutical Science

View All Issues

The main mission of the journal «ScienceRise: Pharmaceutical Science» – dissemination of the results of scientific research aimed at ensuring the quality of pharmaceutical assistance to the population through targeted search and modern pharmaceutical development of innovative medicines, the creation of modern quality management systems at pharmaceutical enterprises in the industry.

In the journal «ScienceRise: Pharmaceutical Science» publishes research designed and implemented taking into account the Quality by design concept with widespread use of computational methods.

The journal is intended for scientists, pharmacists, doctors, educators, and healthcare professionals.

Innovations in pharmaceutical science - for practical use.

 

Drawing up the items of the publication ethics policy of the journal «ScienceRise: Pharmaceutical Science» Editors followed the recommendations of Committee on Publication Ethics (COPE).